Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Advanced Micro Devices - Moderated (AMD) -- Ignore unavailable to you. Want to Upgrade?

To: Road Walker who wrote (43857)	6/11/2001 8:43:25 PM
From: bacchus_ii	Read Replies (2) \| Respond to of 275872

<Would drug companies continue the same level of, say, cancer research? When you decrease the incentive for new product development, doesn't that decrease the investment and risk that individuals and companies are willing to wager? Doesn't that stifle innovation rather than promote innovation?> Yes, yes sure, at some point those drug company, making tremendous profit, stop research because new treatment could permit people to completely recover and stop buying old drug that only keep theme alive long enough for those drug co. to make many years of profit. In many case, unreasonable long-term exclusive right stop the need of innovation. AMD has been 3 or 5 yeas profit less and, in the end, came with the athlon, while Intel making truck load of profit was keeping the Pentium with very little improvement. Profit ===> innovation !!! are you kidding... Gottfried